Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

1.76
Delayed Data
As of 10:29am ET
 -0.01 / -0.56%
Today’s Change
0.67
Today|||52-Week Range
1.85
+45.45%
Year-to-Date
Will Antares Pharma (ATRS) Continue to Surge Higher?
Sep 27 / Zacks.com - Paid Partner Content
Align Technology: Invisalign Growth Continues Globally
Sep 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.77
Today’s open1.77
Day’s range1.75 - 1.78
Volume159,711
Average volume (3 months)975,923
Market cap$274.5M
Dividend yield--
Data as of 10:29am ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+48.15%
Earnings growth (this year)-7.14%
Earnings growth (next 5 years)+54.50%
Revenue growth (last year)+72.28%
P/E ratioNM
Price/Sales3.88
Price/Book4.09

Competitors

 Today’s
change
Today’s
% change
TNDMTandem Diabetes Care...+0.12+1.63%
ELOSSyneron Medical Ltd+0.06+0.87%
UTMDUtah Medical Product...0.000.00%
TCMDTactile Systems Tech...+0.88+5.03%
Data as of 10:45am ET, 09/30/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$45.7M
Annual profit (last year)-$20.7M
Net profit margin-45.25%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Robert F. Apple
Chief Financial Officer, VP-Finance &
Controller
Keith Muckenhirn
Corporate headquarters
Ewing, New Jersey

Forecasts

Search for Jobs